Acute soluble fibre supplementation has no impact on reducing post-prandial glucose excursions in adults with cystic fibrosis and glucose intolerance

Ann Endocrinol (Paris). 2023 Dec;84(6):767-772. doi: 10.1016/j.ando.2023.02.001. Epub 2023 Feb 9.

Abstract

Background: Cystic fibrosis (CF)-related diabetes (CFRD) is a common comorbidity in CF. In CFRD, fasting blood glucose level is often normal, but post-prandial glycaemia (PPG) is problematic. Elevated PPG has been associated to a higher risk of developing CFRD, a worst clinical state and a lower pulmonary function. Interventional studies in type 2 diabetes have demonstrated a beneficial impact of fibre supplement on PPG.

Methods: Our objective is to evaluate the efficiency of 2 doses of a soluble fibre supplement to lower PPG in CF patients with glucose intolerance (pre-diabetic or CFRD patients). This is a double-blinded crossover interventional study with three interventions: placebo or psyllium fibre (5.1g or 7.7g) of soluble fibre consumed before breakfast. A second meal (lunch) is also eaten four hours later to evaluate a second meal effect. Blood glucose and insulin were measured during the interventions.

Results: In 14 adult CF patients with impaired glucose tolerance (IGT; n=10) or CFRD (n=4), we observed no beneficial effect of fibre supplementation on PPG for both meals. However, all blood glucose levels were lower after the lunch compared to breakfast in spite of the higher carbohydrate content.

Conclusion: An acute treatment with fibre supplementation had no effect on blood glucose control in patients with CF-IGT or CFRD.

Keywords: CF-related diabetes; Cystic fibrosis; Fibre; Nutrition; Supplementation.

MeSH terms

  • Adult
  • Blood Glucose
  • Cystic Fibrosis* / complications
  • Diabetes Mellitus*
  • Diabetes Mellitus, Type 2* / complications
  • Glucose Intolerance*
  • Glucose Tolerance Test
  • Humans
  • Insulin

Substances

  • Blood Glucose
  • Insulin